Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 150 of 150

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
3C Patch for treating diabetic foot ulcersMTG66
Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrenceTA810
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitisTA814
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissectionIPG733
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitorsTA813
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Avalglucosidase alfa for treating Pompe diseaseTA821
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Belimumab for treating lupus nephritis (terminated appraisal)TA806
Bioresorbable stent implantation to treat coronary artery diseaseIPG732
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Brolucizumab for treating diabetic macular oedemaTA820
Cefiderocol for treating severe drug-resistant gram-negative bacterial infectionsHTE2
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infectionsHTE1
Cemiplimab for treating advanced cutaneous squamous cell carcinomaTA802
Colorectal cancerQS20
Contrast-enhanced spectral mammography for breast cancerMIB304
Cyanoacrylate glue for hernia mesh fixationMIB301
d-Nav insulin management app for type 2 diabetesMIB285
Dapagliflozin for treating chronic kidney diseaseTA775
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Depression in adults: treatment and managementNG222
Diabetes in children and young peopleQS125
Differential target multiplexed spinal cord stimulation for chronic lower back and leg painMIB305
Diroximel fumarate for treating relapsing–remitting multiple sclerosisTA794
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal)TA811
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesDG46
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Endoanchoring systems in endovascular aortic aneurysm repairIPG725
Endoscopic balloon dilation for subglottic or tracheal stenosisIPG719
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachIPG717
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)TA797
Epilepsies in children, young people and adultsNG217
Faecal microbiota transplant for recurrent Clostridioides difficile infectionMTG71
Faricimab for treating diabetic macular oedemaTA799
Faricimab for treating wet age-related macular degenerationTA800
Fenfluramine for treating seizures associated with Dravet syndromeTA808
Fetal alcohol spectrum disorderQS204
Fever in under 5sQS64
Filgotinib for treating moderately to severely active ulcerative colitisTA792
Focal resurfacing implants to treat articular cartilage damage in the kneeIPG734
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
Fremanezumab for preventing migraineTA764
Gout: diagnosis and managementNG219
Granulox for managing chronic non-healing woundsMIB296
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDsTA815
Ibrutinib for treating Waldenstrom's macroglobulinaemiaTA795
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglyceridesTA805
iFuse for treating chronic sacroiliac joint painMTG39
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney diseaseTA809
Integrated health and social care for people experiencing homelessnessNG214
Intramedullary distraction for lower limb lengtheningIPG718
Intramedullary distraction for upper limb lengtheningIPG722
Joint replacement (primary): hip, knee and shoulderQS206
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Lenus COPD Support Service for remotely managing chronic obstructive pulmonary diseaseMIB300
Liposuction for chronic lipoedemaIPG721
Liposuction for chronic lymphoedemaIPG723
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Melanoma: assessment and managementNG14
Mental wellbeing at workNG212
Microwave ablation for primary or metastatic cancer in the lungIPG716
MiraQ for assessing graft flow during coronary artery bypass graft surgeryMTG8
Multiple sclerosis in adults: managementNG220
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
Neonatal parenteral nutritionQS205
Nerve graft for corneal denervationIPG729
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrenceTA817
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesotheliomaTA818
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)TA762
Otitis media (acute): antimicrobial prescribingNG91
Palforzia for treating peanut allergy in children and young peopleTA769
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuriaTA778
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerTA801
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitisIPG720
Peristeen Plus transanal irrigation system for managing bowel dysfunctionMTG36
PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascitesMTG9
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeIPG724
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
PLGF-based testing to help diagnose suspected preterm pre-eclampsiaDG49
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancerTA812
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseDG45
Preterm labour and birthNG25
ProciseDx point-of-care platform for inflammatory bowel diseaseMIB302
Prontosan for treating acute and chronic woundsMTG67
Reducing sexually transmitted infectionsNG221
RespiraSense for continuously monitoring respiratory rateMIB299
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA803
Romosozumab for treating severe osteoporosisTA791
Roxadustat for treating symptomatic anaemia in chronic kidney diseaseTA807
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapiesTA819
SecurAcath for securing percutaneous cathetersMTG34
SecurePort IV tissue adhesive for use with percutaneous cathetersMIB288
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
Setmelanotide for treating obesity caused by LEPR or POMC deficiencyHST21
Sleepio to treat insomnia and insomnia symptomsMTG70
Social work with adults experiencing complex needsNG216
Social, emotional and mental wellbeing in primary and secondary educationNG223
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
Stereotactic radiosurgery for trigeminal neuralgiaIPG715
Stockholm3 for prostate cancer screeningMIB303
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritisIPG726
Superficial venous arterialisation for chronic limb threatening ischaemiaIPG736
Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus)IPG727
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)TA782
Teduglutide for treating short bowel syndromeTA804
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
The Insides System for managing intestinal failureMIB286
Thopaz+ portable digital system for managing chest drainsMTG37
Transcatheter tricuspid valve annuloplasty for tricuspid regurgitationIPG730
Transcatheter tricuspid valve leaflet repair for tricuspid regurgitationIPG731
Transcutaneous electrical neuromuscular stimulation for urinary incontinenceIPG735
TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failureMIB298
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Type 1 diabetes in adults: diagnosis and managementNG17
Type 2 diabetes in adults: managementNG28
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Urinary tract infection in children and young peopleQS36
Urinary tract infection in under 16s: diagnosis and managementNG224
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Vaccine uptake in the general populationNG218
Vaccine uptake in under 19sQS145
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Vertebral body tethering for idiopathic scoliosis in children and young peopleIPG728
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295

Results per page

  1. 10
  2. 25
  3. 50
  4. All